nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—ALB—acquired immunodeficiency syndrome	0.219	1	CbGaD
Levothyroxine—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0407	0.0719	CbGbCtD
Levothyroxine—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0395	0.0698	CbGbCtD
Levothyroxine—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0384	0.0678	CbGbCtD
Levothyroxine—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.0373	0.0658	CbGbCtD
Levothyroxine—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0357	0.0631	CbGbCtD
Levothyroxine—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0357	0.0631	CbGbCtD
Levothyroxine—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.0337	0.0595	CbGbCtD
Levothyroxine—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.0337	0.0595	CbGbCtD
Levothyroxine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0188	0.0332	CbGbCtD
Levothyroxine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0188	0.0332	CbGbCtD
Levothyroxine—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0185	0.0326	CbGbCtD
Levothyroxine—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0177	0.0313	CbGbCtD
Levothyroxine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0143	0.0252	CbGbCtD
Levothyroxine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0143	0.0252	CbGbCtD
Levothyroxine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0141	0.0249	CbGbCtD
Levothyroxine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0137	0.0242	CbGbCtD
Levothyroxine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0127	0.0225	CbGbCtD
Levothyroxine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.011	0.0194	CbGbCtD
Levothyroxine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0107	0.0189	CbGbCtD
Levothyroxine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00965	0.0171	CbGbCtD
Levothyroxine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00965	0.0171	CbGbCtD
Levothyroxine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00926	0.0163	CbGbCtD
Levothyroxine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00898	0.0159	CbGbCtD
Levothyroxine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00844	0.0149	CbGbCtD
Levothyroxine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00844	0.0149	CbGbCtD
Levothyroxine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00763	0.0135	CbGbCtD
Levothyroxine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00763	0.0135	CbGbCtD
Levothyroxine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00716	0.0126	CbGbCtD
Levothyroxine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00659	0.0116	CbGbCtD
Levothyroxine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0064	0.0113	CbGbCtD
Levothyroxine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00578	0.0102	CbGbCtD
Levothyroxine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00578	0.0102	CbGbCtD
Levothyroxine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00555	0.00979	CbGbCtD
Levothyroxine—SERPINA7—blood plasma—acquired immunodeficiency syndrome	0.00405	0.0628	CbGeAlD
Levothyroxine—TTR—blood plasma—acquired immunodeficiency syndrome	0.00186	0.0289	CbGeAlD
Levothyroxine—SERPINA7—blood—acquired immunodeficiency syndrome	0.00148	0.023	CbGeAlD
Levothyroxine—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.00147	0.0228	CbGeAlD
Levothyroxine—SERPINA7—bone marrow—acquired immunodeficiency syndrome	0.00143	0.0223	CbGeAlD
Levothyroxine—SERPINA7—spinal cord—acquired immunodeficiency syndrome	0.00143	0.0222	CbGeAlD
Levothyroxine—SERPINA7—nervous system—acquired immunodeficiency syndrome	0.0012	0.0187	CbGeAlD
Levothyroxine—SERPINA7—central nervous system—acquired immunodeficiency syndrome	0.00116	0.018	CbGeAlD
Levothyroxine—SLC7A5—retina—acquired immunodeficiency syndrome	0.00104	0.0162	CbGeAlD
Levothyroxine—TTR—retina—acquired immunodeficiency syndrome	0.00102	0.0158	CbGeAlD
Levothyroxine—SLCO4C1—blood—acquired immunodeficiency syndrome	0.000955	0.0148	CbGeAlD
Levothyroxine—SLCO4C1—bone marrow—acquired immunodeficiency syndrome	0.000924	0.0144	CbGeAlD
Levothyroxine—SLC7A5—skin of body—acquired immunodeficiency syndrome	0.000917	0.0142	CbGeAlD
Levothyroxine—SLCO4A1—retina—acquired immunodeficiency syndrome	0.000912	0.0142	CbGeAlD
Levothyroxine—SLCO4C1—vagina—acquired immunodeficiency syndrome	0.000885	0.0137	CbGeAlD
Levothyroxine—THRA—spinal cord—acquired immunodeficiency syndrome	0.000882	0.0137	CbGeAlD
Levothyroxine—TTR—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.00087	0.101	CbGpPWpGaD
Levothyroxine—SLCO1B3—vagina—acquired immunodeficiency syndrome	0.000861	0.0134	CbGeAlD
Levothyroxine—THRB—vagina—acquired immunodeficiency syndrome	0.000849	0.0132	CbGeAlD
Levothyroxine—SLCO4C1—lung—acquired immunodeficiency syndrome	0.000837	0.013	CbGeAlD
Levothyroxine—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000833	0.0129	CbGeAlD
Levothyroxine—SLCO1B3—lung—acquired immunodeficiency syndrome	0.000814	0.0126	CbGeAlD
Levothyroxine—THRB—lung—acquired immunodeficiency syndrome	0.000803	0.0125	CbGeAlD
Levothyroxine—THRA—lung—acquired immunodeficiency syndrome	0.000803	0.0125	CbGeAlD
Levothyroxine—SLC16A2—spinal cord—acquired immunodeficiency syndrome	0.000799	0.0124	CbGeAlD
Levothyroxine—SLC16A2—vagina—acquired immunodeficiency syndrome	0.000769	0.0119	CbGeAlD
Levothyroxine—THRB—nervous system—acquired immunodeficiency syndrome	0.000743	0.0115	CbGeAlD
Levothyroxine—THRA—nervous system—acquired immunodeficiency syndrome	0.000743	0.0115	CbGeAlD
Levothyroxine—SLC7A5—lymphoid tissue—acquired immunodeficiency syndrome	0.000743	0.0115	CbGeAlD
Levothyroxine—SLCO1C1—spinal cord—acquired immunodeficiency syndrome	0.000734	0.0114	CbGeAlD
Levothyroxine—SLC7A5—digestive system—acquired immunodeficiency syndrome	0.000733	0.0114	CbGeAlD
Levothyroxine—SLC16A2—lung—acquired immunodeficiency syndrome	0.000727	0.0113	CbGeAlD
Levothyroxine—TTR—lymphoid tissue—acquired immunodeficiency syndrome	0.000723	0.0112	CbGeAlD
Levothyroxine—THRB—central nervous system—acquired immunodeficiency syndrome	0.000716	0.0111	CbGeAlD
Levothyroxine—THRA—central nervous system—acquired immunodeficiency syndrome	0.000716	0.0111	CbGeAlD
Levothyroxine—TTR—digestive system—acquired immunodeficiency syndrome	0.000714	0.0111	CbGeAlD
Levothyroxine—SLC7A5—blood—acquired immunodeficiency syndrome	0.000699	0.0109	CbGeAlD
Levothyroxine—TTR—blood—acquired immunodeficiency syndrome	0.000681	0.0106	CbGeAlD
Levothyroxine—SLC7A5—bone marrow—acquired immunodeficiency syndrome	0.000676	0.0105	CbGeAlD
Levothyroxine—SLC16A2—nervous system—acquired immunodeficiency syndrome	0.000674	0.0105	CbGeAlD
Levothyroxine—SLC7A5—spinal cord—acquired immunodeficiency syndrome	0.000673	0.0105	CbGeAlD
Levothyroxine—TTR—bone marrow—acquired immunodeficiency syndrome	0.000659	0.0102	CbGeAlD
Levothyroxine—TTR—spinal cord—acquired immunodeficiency syndrome	0.000656	0.0102	CbGeAlD
Levothyroxine—SLC16A2—central nervous system—acquired immunodeficiency syndrome	0.000648	0.0101	CbGeAlD
Levothyroxine—SLC7A5—vagina—acquired immunodeficiency syndrome	0.000648	0.0101	CbGeAlD
Levothyroxine—SLCO4A1—digestive system—acquired immunodeficiency syndrome	0.00064	0.00995	CbGeAlD
Levothyroxine—Liotrix—ALB—acquired immunodeficiency syndrome	0.000638	0.578	CrCbGaD
Levothyroxine—SLCO1C1—nervous system—acquired immunodeficiency syndrome	0.000618	0.0096	CbGeAlD
Levothyroxine—SLC7A5—lung—acquired immunodeficiency syndrome	0.000613	0.00951	CbGeAlD
Levothyroxine—SLCO4C1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.0006	0.0696	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.0006	0.0696	CbGpPWpGaD
Levothyroxine—TTR—lung—acquired immunodeficiency syndrome	0.000597	0.00927	CbGeAlD
Levothyroxine—SLCO1C1—central nervous system—acquired immunodeficiency syndrome	0.000595	0.00924	CbGeAlD
Levothyroxine—SLCO4A1—spinal cord—acquired immunodeficiency syndrome	0.000588	0.00913	CbGeAlD
Levothyroxine—THRA—brain—acquired immunodeficiency syndrome	0.000568	0.00882	CbGeAlD
Levothyroxine—THRB—brain—acquired immunodeficiency syndrome	0.000568	0.00882	CbGeAlD
Levothyroxine—SLC7A5—nervous system—acquired immunodeficiency syndrome	0.000567	0.00881	CbGeAlD
Levothyroxine—SLCO4A1—vagina—acquired immunodeficiency syndrome	0.000566	0.00878	CbGeAlD
Levothyroxine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000564	0.00877	CbGeAlD
Levothyroxine—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000564	0.00875	CbGeAlD
Levothyroxine—TTR—nervous system—acquired immunodeficiency syndrome	0.000553	0.00858	CbGeAlD
Levothyroxine—THRB—lymph node—acquired immunodeficiency syndrome	0.000549	0.00853	CbGeAlD
Levothyroxine—THRA—lymph node—acquired immunodeficiency syndrome	0.000549	0.00853	CbGeAlD
Levothyroxine—SLC7A5—central nervous system—acquired immunodeficiency syndrome	0.000546	0.00848	CbGeAlD
Levothyroxine—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000537	0.00834	CbGeAlD
Levothyroxine—SLCO4A1—lung—acquired immunodeficiency syndrome	0.000535	0.00831	CbGeAlD
Levothyroxine—TTR—central nervous system—acquired immunodeficiency syndrome	0.000532	0.00826	CbGeAlD
Levothyroxine—SLC16A2—brain—acquired immunodeficiency syndrome	0.000515	0.00799	CbGeAlD
Levothyroxine—SLCO1C1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000503	0.0583	CbGpPWpGaD
Levothyroxine—SLC16A2—lymph node—acquired immunodeficiency syndrome	0.000497	0.00772	CbGeAlD
Levothyroxine—SLCO4A1—nervous system—acquired immunodeficiency syndrome	0.000495	0.00769	CbGeAlD
Levothyroxine—SLCO4A1—central nervous system—acquired immunodeficiency syndrome	0.000477	0.00741	CbGeAlD
Levothyroxine—SLCO1C1—brain—acquired immunodeficiency syndrome	0.000472	0.00734	CbGeAlD
Levothyroxine—Liothyronine—ALB—acquired immunodeficiency syndrome	0.000466	0.422	CrCbGaD
Levothyroxine—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000459	0.00712	CbGeAlD
Levothyroxine—SLCO1C1—lymph node—acquired immunodeficiency syndrome	0.000457	0.00709	CbGeAlD
Levothyroxine—SLC7A5—brain—acquired immunodeficiency syndrome	0.000434	0.00673	CbGeAlD
Levothyroxine—TTR—brain—acquired immunodeficiency syndrome	0.000422	0.00656	CbGeAlD
Levothyroxine—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000421	0.00654	CbGeAlD
Levothyroxine—SLC7A5—lymph node—acquired immunodeficiency syndrome	0.000419	0.00651	CbGeAlD
Levothyroxine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.0004	0.0062	CbGeAlD
Levothyroxine—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000383	0.00595	CbGeAlD
Levothyroxine—SLCO4A1—brain—acquired immunodeficiency syndrome	0.000379	0.00588	CbGeAlD
Levothyroxine—SLCO4A1—lymph node—acquired immunodeficiency syndrome	0.000366	0.00568	CbGeAlD
Levothyroxine—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000355	0.00551	CbGeAlD
Levothyroxine—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000342	0.0053	CbGeAlD
Levothyroxine—CYP2C8—blood—acquired immunodeficiency syndrome	0.000305	0.00474	CbGeAlD
Levothyroxine—SLCO1B3—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000285	0.033	CbGpPWpGaD
Levothyroxine—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000283	0.00439	CbGeAlD
Levothyroxine—Tension—Delavirdine—acquired immunodeficiency syndrome	0.000281	0.00199	CcSEcCtD
Levothyroxine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00028	0.00199	CcSEcCtD
Levothyroxine—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.00028	0.00199	CcSEcCtD
Levothyroxine—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.00028	0.00199	CcSEcCtD
Levothyroxine—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000279	0.00199	CcSEcCtD
Levothyroxine—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.00197	CcSEcCtD
Levothyroxine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000276	0.00196	CcSEcCtD
Levothyroxine—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000275	0.00196	CcSEcCtD
Levothyroxine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000275	0.00195	CcSEcCtD
Levothyroxine—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000273	0.00194	CcSEcCtD
Levothyroxine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00194	CcSEcCtD
Levothyroxine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000273	0.00194	CcSEcCtD
Levothyroxine—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000271	0.00193	CcSEcCtD
Levothyroxine—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000271	0.00421	CbGeAlD
Levothyroxine—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00027	0.00192	CcSEcCtD
Levothyroxine—ALB—brain—acquired immunodeficiency syndrome	0.00027	0.00419	CbGeAlD
Levothyroxine—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000269	0.00191	CcSEcCtD
Levothyroxine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000268	0.00191	CcSEcCtD
Levothyroxine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000268	0.00191	CcSEcCtD
Levothyroxine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000268	0.0019	CcSEcCtD
Levothyroxine—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.00188	CcSEcCtD
Levothyroxine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000264	0.00188	CcSEcCtD
Levothyroxine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000264	0.00188	CcSEcCtD
Levothyroxine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.00187	CcSEcCtD
Levothyroxine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000263	0.00187	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000262	0.00186	CcSEcCtD
Levothyroxine—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000261	0.00186	CcSEcCtD
Levothyroxine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000261	0.00186	CcSEcCtD
Levothyroxine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.00186	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000261	0.00186	CcSEcCtD
Levothyroxine—ALB—lymph node—acquired immunodeficiency syndrome	0.00026	0.00404	CbGeAlD
Levothyroxine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00026	0.00185	CcSEcCtD
Levothyroxine—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.00184	CcSEcCtD
Levothyroxine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000259	0.00184	CcSEcCtD
Levothyroxine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.00184	CcSEcCtD
Levothyroxine—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000258	0.00184	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000257	0.00183	CcSEcCtD
Levothyroxine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.00183	CcSEcCtD
Levothyroxine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000257	0.00182	CcSEcCtD
Levothyroxine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000254	0.00181	CcSEcCtD
Levothyroxine—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000254	0.00181	CcSEcCtD
Levothyroxine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000254	0.00181	CcSEcCtD
Levothyroxine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000254	0.00181	CcSEcCtD
Levothyroxine—Shock—Indinavir—acquired immunodeficiency syndrome	0.000254	0.00181	CcSEcCtD
Levothyroxine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000254	0.0018	CcSEcCtD
Levothyroxine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000253	0.0018	CcSEcCtD
Levothyroxine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000253	0.0018	CcSEcCtD
Levothyroxine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000253	0.0018	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000253	0.0018	CcSEcCtD
Levothyroxine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000253	0.0018	CcSEcCtD
Levothyroxine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000253	0.0018	CcSEcCtD
Levothyroxine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000252	0.00179	CcSEcCtD
Levothyroxine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000252	0.00179	CcSEcCtD
Levothyroxine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000252	0.00179	CcSEcCtD
Levothyroxine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000251	0.00178	CcSEcCtD
Levothyroxine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00025	0.00178	CcSEcCtD
Levothyroxine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000249	0.00177	CcSEcCtD
Levothyroxine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000249	0.00177	CcSEcCtD
Levothyroxine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000249	0.00177	CcSEcCtD
Levothyroxine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.00176	CcSEcCtD
Levothyroxine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000247	0.00176	CcSEcCtD
Levothyroxine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.00175	CcSEcCtD
Levothyroxine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000246	0.00175	CcSEcCtD
Levothyroxine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.00173	CcSEcCtD
Levothyroxine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.00173	CcSEcCtD
Levothyroxine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.00172	CcSEcCtD
Levothyroxine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00024	0.00171	CcSEcCtD
Levothyroxine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00024	0.0017	CcSEcCtD
Levothyroxine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000239	0.0017	CcSEcCtD
Levothyroxine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00169	CcSEcCtD
Levothyroxine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.00169	CcSEcCtD
Levothyroxine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.00169	CcSEcCtD
Levothyroxine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000237	0.00169	CcSEcCtD
Levothyroxine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.00168	CcSEcCtD
Levothyroxine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.00168	CcSEcCtD
Levothyroxine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.00167	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000235	0.00167	CcSEcCtD
Levothyroxine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000234	0.00166	CcSEcCtD
Levothyroxine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000234	0.00166	CcSEcCtD
Levothyroxine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.00166	CcSEcCtD
Levothyroxine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00166	CcSEcCtD
Levothyroxine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000233	0.00166	CcSEcCtD
Levothyroxine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000232	0.00165	CcSEcCtD
Levothyroxine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000232	0.00165	CcSEcCtD
Levothyroxine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00023	0.00164	CcSEcCtD
Levothyroxine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00023	0.00164	CcSEcCtD
Levothyroxine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00023	0.00163	CcSEcCtD
Levothyroxine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.00163	CcSEcCtD
Levothyroxine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000229	0.00163	CcSEcCtD
Levothyroxine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.00163	CcSEcCtD
Levothyroxine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000229	0.00163	CcSEcCtD
Levothyroxine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00162	CcSEcCtD
Levothyroxine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00162	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000227	0.00161	CcSEcCtD
Levothyroxine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000227	0.00161	CcSEcCtD
Levothyroxine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000226	0.00161	CcSEcCtD
Levothyroxine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000226	0.00161	CcSEcCtD
Levothyroxine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000226	0.0016	CcSEcCtD
Levothyroxine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.0016	CcSEcCtD
Levothyroxine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.0016	CcSEcCtD
Levothyroxine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.00159	CcSEcCtD
Levothyroxine—SLCO1A2—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000224	0.0259	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000223	0.0258	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000223	0.0258	CbGpPWpGaD
Levothyroxine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000223	0.00158	CcSEcCtD
Levothyroxine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000223	0.00158	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.00158	CcSEcCtD
Levothyroxine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00158	CcSEcCtD
Levothyroxine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000221	0.00157	CcSEcCtD
Levothyroxine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00022	0.00157	CcSEcCtD
Levothyroxine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.00157	CcSEcCtD
Levothyroxine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000219	0.00156	CcSEcCtD
Levothyroxine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000219	0.00156	CcSEcCtD
Levothyroxine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000219	0.00156	CcSEcCtD
Levothyroxine—ABCB1—retina—acquired immunodeficiency syndrome	0.000219	0.0034	CbGeAlD
Levothyroxine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000218	0.00155	CcSEcCtD
Levothyroxine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000218	0.00155	CcSEcCtD
Levothyroxine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.00155	CcSEcCtD
Levothyroxine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.00155	CcSEcCtD
Levothyroxine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000217	0.00337	CbGeAlD
Levothyroxine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.00154	CcSEcCtD
Levothyroxine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.00153	CcSEcCtD
Levothyroxine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000215	0.00153	CcSEcCtD
Levothyroxine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000213	0.00151	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.00151	CcSEcCtD
Levothyroxine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.00151	CcSEcCtD
Levothyroxine—SLCO1B3—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000211	0.0245	CbGpPWpGaD
Levothyroxine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000211	0.0015	CcSEcCtD
Levothyroxine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.0015	CcSEcCtD
Levothyroxine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.0015	CcSEcCtD
Levothyroxine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.0015	CcSEcCtD
Levothyroxine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00021	0.00149	CcSEcCtD
Levothyroxine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.00149	CcSEcCtD
Levothyroxine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.00149	CcSEcCtD
Levothyroxine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00148	CcSEcCtD
Levothyroxine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000209	0.00148	CcSEcCtD
Levothyroxine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000208	0.00148	CcSEcCtD
Levothyroxine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.00148	CcSEcCtD
Levothyroxine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000207	0.00147	CcSEcCtD
Levothyroxine—ALB—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.000207	0.024	CbGpPWpGaD
Levothyroxine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000207	0.00321	CbGeAlD
Levothyroxine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.00147	CcSEcCtD
Levothyroxine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.00146	CcSEcCtD
Levothyroxine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000205	0.00146	CcSEcCtD
Levothyroxine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.00145	CcSEcCtD
Levothyroxine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000204	0.00145	CcSEcCtD
Levothyroxine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000204	0.00145	CcSEcCtD
Levothyroxine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000204	0.00145	CcSEcCtD
Levothyroxine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000203	0.00144	CcSEcCtD
Levothyroxine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000202	0.00144	CcSEcCtD
Levothyroxine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000202	0.00143	CcSEcCtD
Levothyroxine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000201	0.00143	CcSEcCtD
Levothyroxine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.00143	CcSEcCtD
Levothyroxine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000201	0.00143	CcSEcCtD
Levothyroxine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.00143	CcSEcCtD
Levothyroxine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.00143	CcSEcCtD
Levothyroxine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000201	0.00143	CcSEcCtD
Levothyroxine—Headache—Stavudine—acquired immunodeficiency syndrome	0.0002	0.00142	CcSEcCtD
Levothyroxine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.0002	0.00142	CcSEcCtD
Levothyroxine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.00142	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.00142	CcSEcCtD
Levothyroxine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000199	0.00142	CcSEcCtD
Levothyroxine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000198	0.00141	CcSEcCtD
Levothyroxine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000198	0.00141	CcSEcCtD
Levothyroxine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000197	0.0014	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.0014	CcSEcCtD
Levothyroxine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000196	0.0014	CcSEcCtD
Levothyroxine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000196	0.0014	CcSEcCtD
Levothyroxine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.00139	CcSEcCtD
Levothyroxine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.00139	CcSEcCtD
Levothyroxine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.00138	CcSEcCtD
Levothyroxine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000193	0.00137	CcSEcCtD
Levothyroxine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000193	0.00137	CcSEcCtD
Levothyroxine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.00137	CcSEcCtD
Levothyroxine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.00137	CcSEcCtD
Levothyroxine—THRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—acquired immunodeficiency syndrome	0.000192	0.0222	CbGpPWpGaD
Levothyroxine—THRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—acquired immunodeficiency syndrome	0.000192	0.0222	CbGpPWpGaD
Levothyroxine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.00136	CcSEcCtD
Levothyroxine—SLCO1B1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000191	0.0222	CbGpPWpGaD
Levothyroxine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.00136	CcSEcCtD
Levothyroxine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00019	0.00135	CcSEcCtD
Levothyroxine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00019	0.00135	CcSEcCtD
Levothyroxine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00019	0.00135	CcSEcCtD
Levothyroxine—CYP2C8—brain—acquired immunodeficiency syndrome	0.000189	0.00294	CbGeAlD
Levothyroxine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.00134	CcSEcCtD
Levothyroxine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.00134	CcSEcCtD
Levothyroxine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000187	0.00133	CcSEcCtD
Levothyroxine—SLCO1C1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000187	0.0216	CbGpPWpGaD
Levothyroxine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.00132	CcSEcCtD
Levothyroxine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.00132	CcSEcCtD
Levothyroxine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000185	0.00132	CcSEcCtD
Levothyroxine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.00132	CcSEcCtD
Levothyroxine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000184	0.00131	CcSEcCtD
Levothyroxine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000184	0.00131	CcSEcCtD
Levothyroxine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000183	0.0013	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.00128	CcSEcCtD
Levothyroxine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.00127	CcSEcCtD
Levothyroxine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.00127	CcSEcCtD
Levothyroxine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.00126	CcSEcCtD
Levothyroxine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.00126	CcSEcCtD
Levothyroxine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000177	0.00126	CcSEcCtD
Levothyroxine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000176	0.00125	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.00125	CcSEcCtD
Levothyroxine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000175	0.00124	CcSEcCtD
Levothyroxine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.00124	CcSEcCtD
Levothyroxine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000175	0.00124	CcSEcCtD
Levothyroxine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.00124	CcSEcCtD
Levothyroxine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000173	0.00123	CcSEcCtD
Levothyroxine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.00122	CcSEcCtD
Levothyroxine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.00122	CcSEcCtD
Levothyroxine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.00121	CcSEcCtD
Levothyroxine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.00121	CcSEcCtD
Levothyroxine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.00121	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.00121	CcSEcCtD
Levothyroxine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000168	0.00261	CbGeAlD
Levothyroxine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.00119	CcSEcCtD
Levothyroxine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.00119	CcSEcCtD
Levothyroxine—SLCO1A2—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000166	0.0192	CbGpPWpGaD
Levothyroxine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.00117	CcSEcCtD
Levothyroxine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.00117	CcSEcCtD
Levothyroxine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.00117	CcSEcCtD
Levothyroxine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.00117	CcSEcCtD
Levothyroxine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.00117	CcSEcCtD
Levothyroxine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000164	0.00117	CcSEcCtD
Levothyroxine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.00116	CcSEcCtD
Levothyroxine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000163	0.00116	CcSEcCtD
Levothyroxine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000163	0.00116	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.00115	CcSEcCtD
Levothyroxine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000162	0.00115	CcSEcCtD
Levothyroxine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000162	0.00251	CbGeAlD
Levothyroxine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.00113	CcSEcCtD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000159	0.0185	CbGpPWpGaD
Levothyroxine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.00112	CcSEcCtD
Levothyroxine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.00111	CcSEcCtD
Levothyroxine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.00111	CcSEcCtD
Levothyroxine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000156	0.00242	CbGeAlD
Levothyroxine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000155	0.0011	CcSEcCtD
Levothyroxine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.0011	CcSEcCtD
Levothyroxine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.00109	CcSEcCtD
Levothyroxine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000154	0.00239	CbGeAlD
Levothyroxine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.00109	CcSEcCtD
Levothyroxine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000153	0.00109	CcSEcCtD
Levothyroxine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.00109	CcSEcCtD
Levothyroxine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.00109	CcSEcCtD
Levothyroxine—TTR—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	0.000152	0.0176	CbGpPWpGaD
Levothyroxine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.00106	CcSEcCtD
Levothyroxine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000148	0.00105	CcSEcCtD
Levothyroxine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.00105	CcSEcCtD
Levothyroxine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.00105	CcSEcCtD
Levothyroxine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.00104	CcSEcCtD
Levothyroxine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.00104	CcSEcCtD
Levothyroxine—ABCB1—blood—acquired immunodeficiency syndrome	0.000146	0.00227	CbGeAlD
Levothyroxine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.00104	CcSEcCtD
Levothyroxine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.00103	CcSEcCtD
Levothyroxine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.00101	CcSEcCtD
Levothyroxine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.00101	CcSEcCtD
Levothyroxine—SLCO1B1—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000142	0.0164	CbGpPWpGaD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000142	0.0164	CbGpPWpGaD
Levothyroxine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000142	0.0022	CbGeAlD
Levothyroxine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000141	0.00219	CbGeAlD
Levothyroxine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000996	CcSEcCtD
Levothyroxine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000985	CcSEcCtD
Levothyroxine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000975	CcSEcCtD
Levothyroxine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000967	CcSEcCtD
Levothyroxine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000966	CcSEcCtD
Levothyroxine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000136	0.00211	CbGeAlD
Levothyroxine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000964	CcSEcCtD
Levothyroxine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000961	CcSEcCtD
Levothyroxine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000939	CcSEcCtD
Levothyroxine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000931	CcSEcCtD
Levothyroxine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.00093	CcSEcCtD
Levothyroxine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000925	CcSEcCtD
Levothyroxine—ABCB1—lung—acquired immunodeficiency syndrome	0.000128	0.00199	CbGeAlD
Levothyroxine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000911	CcSEcCtD
Levothyroxine—THRA—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000127	0.0148	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000127	0.0148	CbGpPWpGaD
Levothyroxine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000895	CcSEcCtD
Levothyroxine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000888	CcSEcCtD
Levothyroxine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000887	CcSEcCtD
Levothyroxine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000882	CcSEcCtD
Levothyroxine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000877	CcSEcCtD
Levothyroxine—THRB—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.00012	0.0139	CbGpPWpGaD
Levothyroxine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000119	0.00185	CbGeAlD
Levothyroxine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000836	CcSEcCtD
Levothyroxine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000114	0.00178	CbGeAlD
Levothyroxine—SLCO1B3—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.00011	0.0128	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000106	0.0122	CbGpPWpGaD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	0.000103	0.012	CbGpPWpGaD
Levothyroxine—ABCB1—brain—acquired immunodeficiency syndrome	9.08e-05	0.00141	CbGeAlD
Levothyroxine—ABCB1—lymph node—acquired immunodeficiency syndrome	8.78e-05	0.00136	CbGeAlD
Levothyroxine—SLCO1A2—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	8.67e-05	0.01	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	8.3e-05	0.00962	CbGpPWpGaD
Levothyroxine—SLCO1B1—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	7.41e-05	0.00859	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	7.1e-05	0.00823	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—CCNT1—acquired immunodeficiency syndrome	6.13e-05	0.00711	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—CCNT1—acquired immunodeficiency syndrome	6.13e-05	0.00711	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.91e-05	0.00685	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—IFNA1—acquired immunodeficiency syndrome	5.03e-05	0.00583	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	4.99e-05	0.00579	CbGpPWpGaD
Levothyroxine—SLCO4C1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.78e-05	0.00554	CbGpPWpGaD
Levothyroxine—SLCO4A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.78e-05	0.00554	CbGpPWpGaD
Levothyroxine—TTR—Disease—APOBEC3G—acquired immunodeficiency syndrome	4.77e-05	0.00553	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	4.69e-05	0.00544	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	4.68e-05	0.00542	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	4.68e-05	0.00542	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.64e-05	0.00538	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	4.57e-05	0.0053	CbGpPWpGaD
Levothyroxine—SLC7A5—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.37e-05	0.00507	CbGpPWpGaD
Levothyroxine—TTR—Disease—CCNT1—acquired immunodeficiency syndrome	4.06e-05	0.0047	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	4.05e-05	0.0047	CbGpPWpGaD
Levothyroxine—SLCO1C1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.01e-05	0.00464	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.97e-05	0.0046	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—CSF2—acquired immunodeficiency syndrome	3.94e-05	0.00457	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IL4—acquired immunodeficiency syndrome	3.94e-05	0.00456	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	3.69e-05	0.00427	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—TAT—acquired immunodeficiency syndrome	3.1e-05	0.00359	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	3.07e-05	0.00356	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	3.07e-05	0.00356	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	2.99e-05	0.00346	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	2.92e-05	0.00339	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	2.92e-05	0.00339	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.84e-05	0.00329	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.84e-05	0.00329	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AGPS—acquired immunodeficiency syndrome	2.63e-05	0.00305	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.57e-05	0.00298	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—ALB—acquired immunodeficiency syndrome	2.57e-05	0.00298	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—TAT—acquired immunodeficiency syndrome	2.43e-05	0.00282	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.43e-05	0.00282	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.43e-05	0.00282	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	2.38e-05	0.00276	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.28e-05	0.00265	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.27e-05	0.00263	CbGpPWpGaD
Levothyroxine—SLCO1B3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.27e-05	0.00263	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.22e-05	0.00258	CbGpPWpGaD
Levothyroxine—TTR—Disease—CXCR4—acquired immunodeficiency syndrome	2.13e-05	0.00247	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	2.11e-05	0.00245	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—IL2—acquired immunodeficiency syndrome	2.08e-05	0.00241	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—TAT—acquired immunodeficiency syndrome	2.08e-05	0.00241	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.07e-05	0.0024	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.04e-05	0.00236	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	1.89e-05	0.00219	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	1.89e-05	0.00219	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	1.81e-05	0.00209	CbGpPWpGaD
Levothyroxine—SLCO1A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.78e-05	0.00207	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.77e-05	0.00205	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.76e-05	0.00204	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	1.6e-05	0.00186	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.59e-05	0.00184	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	1.54e-05	0.00179	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	1.53e-05	0.00177	CbGpPWpGaD
Levothyroxine—SLCO1B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.52e-05	0.00177	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	1.52e-05	0.00176	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.49e-05	0.00173	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.49e-05	0.00173	CbGpPWpGaD
Levothyroxine—TTR—Disease—CCR5—acquired immunodeficiency syndrome	1.46e-05	0.00169	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	1.24e-05	0.00144	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	1.22e-05	0.00142	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.21e-05	0.00141	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	1.2e-05	0.00139	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	1.19e-05	0.00138	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	1.17e-05	0.00135	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.15e-05	0.00134	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.14e-05	0.00132	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.12e-05	0.0013	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	1.04e-05	0.00121	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.02e-05	0.00119	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	1.02e-05	0.00118	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	1.01e-05	0.00117	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	1e-05	0.00116	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	9.87e-06	0.00114	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.52e-06	0.0011	CbGpPWpGaD
Levothyroxine—TTR—Disease—CD4—acquired immunodeficiency syndrome	9.17e-06	0.00106	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.06e-06	0.00105	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	8.85e-06	0.00103	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.14e-06	0.000944	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	8.04e-06	0.000932	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	7.84e-06	0.000909	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.74e-06	0.000898	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	6.42e-06	0.000744	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.91e-06	0.000685	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	5.77e-06	0.000669	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	5.45e-06	0.000632	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ALB—acquired immunodeficiency syndrome	5.4e-06	0.000626	CbGpPWpGaD
Levothyroxine—TTR—Disease—IL6—acquired immunodeficiency syndrome	4.96e-06	0.000575	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	4.68e-06	0.000543	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ALB—acquired immunodeficiency syndrome	4.24e-06	0.000492	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	4.14e-06	0.000481	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.88e-06	0.000449	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ALB—acquired immunodeficiency syndrome	3.63e-06	0.000421	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.47e-06	0.000403	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	2.08e-06	0.000242	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	1.82e-06	0.000211	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.12e-06	0.00013	CbGpPWpGaD
